CME Group price target raised to $283 from $279 at Barclays

Barclays raised the firm’s price target on CME Group (CME) to $283 from $279 and keeps an Equal Weight rating on the shares following the Q1 report. The company saw record volumes across multiple products, and volatility has driven collateral balances higher, the analyst tells investors in a research note. The firm thinks the post-earnings weakness in the shares is “entirely macro-related.”